miR-155 Inhibition Sensitizes CD4+ Th Cells for TREG Mediated Suppression

• Heiko F. Stahl ,

  Contributed equally to this work with: Heiko F. Stahl, Tanja Fauti, Nina Ullrich, Tobias Bopp, Jan Kubach

  Affiliation Boehringer Ingelheim Pharma GmbH & Co. KG, Respiratory Diseases Research, Genomics Group, Biberach an der Riss, Germany

  ⨯
• Tanja Fauti ,

  Contributed equally to this work with: Heiko F. Stahl, Tanja Fauti, Nina Ullrich, Tobias Bopp, Jan Kubach

  Affiliation Boehringer Ingelheim Pharma GmbH & Co. KG, Respiratory Diseases Research, Genomics Group, Biberach an der Riss, Germany

  ⨯
• Nina Ullrich ,

  Contributed equally to this work with: Heiko F. Stahl, Tanja Fauti, Nina Ullrich, Tobias Bopp, Jan Kubach

  Affiliation Johannes Gutenberg University, Institute of Immunology, Mainz, Germany

  ⨯
• Tobias Bopp ,

  Contributed equally to this work with: Heiko F. Stahl, Tanja Fauti, Nina Ullrich, Tobias Bopp, Jan Kubach

  Affiliation Johannes Gutenberg University, Institute of Immunology, Mainz, Germany

  ⨯
• Jan Kubach ,

  Contributed equally to this work with: Heiko F. Stahl, Tanja Fauti, Nina Ullrich, Tobias Bopp, Jan Kubach

  Affiliation Johannes Gutenberg University, Department of Dermatology, Mainz, Germany

  ⨯
• Werner Rust,

  Affiliation Boehringer Ingelheim Pharma GmbH & Co. KG, Respiratory Diseases Research, Genomics Group, Biberach an der Riss, Germany

  ⨯
• Paul Labhart,

  Affiliation Genpathway Inc., San Diego, California, United States of America

  ⨯
• Vassili Alexiadis,

  Affiliation Genpathway Inc., San Diego, California, United States of America

  ⨯
• Christian Becker,

  Affiliation Johannes Gutenberg University, Department of Dermatology, Mainz, Germany

  ⨯
• Mathias Hafner,

  Affiliation Institute of Molecular Biology and Cell Culture Technology, University of Applied Sciences, Mannheim, Germany

  ⨯
• Andreas Weith,

  Affiliation Boehringer Ingelheim Pharma GmbH & Co. KG, Respiratory Diseases Research, Genomics Group, Biberach an der Riss, Germany

  ⨯
• Martin C. Lenter,

  Affiliation Boehringer Ingelheim Pharma GmbH & Co. KG, Respiratory Diseases Research, Genomics Group, Biberach an der Riss, Germany

  ⨯
• Helmut Jonuleit,

  Affiliation Johannes Gutenberg University, Department of Dermatology, Mainz, Germany

  ⨯
• Edgar Schmitt,

  Affiliation Johannes Gutenberg University, Institute of Immunology, Mainz, Germany

  ⨯
• Detlev Mennerich

  * E-mail: detlev.mennerich@boehringer-ingelheim.com

  Affiliation Boehringer Ingelheim Pharma GmbH & Co. KG, Respiratory Diseases Research, Genomics Group, Biberach an der Riss, Germany

  ⨯